Browse drugs

…hat CMS4 T-EVs, particularly those generated in the presence of TGF-β1, induce an evolving immunosuppressive phenotype in NK cells.Int…

…ts with NHP CD3, CD28 and 4-1BB, MX485. Binding metrics between MDX2004 and receptors on T cells were generated by using the physiologi…

…rted after tumors reached 50 mm 3. Triplet therapy consisted of Doxil IV on day 1, Flt3L IP on days 1–5, and CD40a IP on days 11, 14,…

… for immunotherapy combinations. For example, the Met inhibitor PF-04217903 potently induced CXCL9-10 and IL-12 expression by hepatocytes, …

… a second laparotomy, tumors were treated with IRE, followed by PBS or CPMV intratumoral injection for the IRE and IRE+CPMV groups,…

…Y, Yao B, Li A, Doleman S, VanderWalde A, Gansert J, Coffin RS. Talimogene laherparepvec improves durable respose rate in patients with advanced melanom…

…ometry of intracellular IFNγ staining.Results APLs derived from HMTEVVRHC elicited up to a 10-fold increase in HLA-A*02:01 binding affini…

… vitro studies have shown that our pH-dependent bispecific TCE, CT-202, binds to the target proteins, human Nectin-4 and human CD3, wi…

…a Revvity IVIS Spectrum. The mice are injected with 0.6 nmol of Herceptin conjugated to Alexa Fluor 647. At given times points, the mice …

…Objective Nintedanib is approved for the treatment of interstitial lung disease (ILD…

…Background Fibrinogenase for injection is an effective antithrombotic agent for eligible patients with…

…ngs (KES) 1920 (46 Intl$) with IPT and KES 1350 (31 Intl$) with fluoxetine. Absenteeism dropped in both treatment arms, by 1.5 days per mo…